Cabaletta Bio Inc (CABA)
Healthcare
Biotechnology
2.70 $
-1.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Cabaletta Bio Inc (CABA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 87.6% of the shares are freely tradable; institutional investors hold 63.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
63.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
1.0%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
87.6%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
27.8%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
163Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| T. Rowe Price Investment Management,Inc. | 9.95 | 11,080,005 | -20.1 | 03/31/2026 |
| Bain Capital Life Sciences Investors, LLC | 8.69 | 9,677,125 | +0.0 | 03/31/2026 |
| Jennison Associates LLC | 8.06 | 8,970,578 | +0.7 | 03/31/2026 |
| Adage Capital Partners Gp LLC | 7.93 | 8,829,758 | +0.0 | 03/31/2026 |
| Millennium Management LLC | 5.30 | 5,903,281 | +115.7 | 03/31/2026 |
| Cormorant Asset Management, LLC | 4.94 | 5,500,000 | +25.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| T. Rowe Price Small-Cap Value | 7.07 | 7,865,614 | +29.3 | 06/30/2026 |
| Vanguard Morn Total Stk Mkt Idx Investor | 4.68 | 5,215,188 | +84.2 | 06/30/2026 |
| T. Rowe Price U.S. SC Value Eq Tr-D | 4.65 | 5,171,813 | +37.3 | 06/30/2026 |
| State Street® SPDR® S&P® Biotech ETF | 4.64 | 5,162,889 | -1.0 | 07/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.